LMAT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LeMaitre Vascular Inc (LMAT) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company demonstrates strong financial growth, positive analyst sentiment, and bullish moving averages. Despite hedge fund selling, the stock's fundamentals and long-term growth potential make it a suitable investment.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. However, the MACD is negative and expanding, suggesting short-term weakness. RSI is neutral at 57.937, and the stock is trading near its pivot level of 109.08 with resistance at 112.746.
Strong Q4 financial performance with revenue up 15.68% YoY, net income up 39.32% YoY, and EPS up 38.78% YoY. Analysts have raised price targets and maintained Buy/Outperform ratings, citing impressive sales growth, margin expansion, and international growth.
Hedge funds have significantly increased selling activity (up 398.42% last quarter). The MACD is negative, and short-term stock trend analysis suggests a slight decline in the next day and week.
In Q4 2025, the company achieved revenue growth of 15.68% YoY, net income growth of 39.32% YoY, and EPS growth of 38.78% YoY. Gross margin also improved to 71.66%, up 3.47% YoY, showcasing strong operational efficiency.
Analysts are optimistic, with Roth Capital, Barrington, and Citizens raising price targets to $117, $105, and $118, respectively. They highlight double-digit organic growth, margin expansion, and strong cash flow as key drivers.
